Stifel Financial Corp lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 13.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 761,125 shares of the pharmacy operator’s stock after selling 120,673 shares during the quarter. Stifel Financial Corp owned approximately 0.07% of Walgreens Boots Alliance worth $59,450,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Hudock Capital Group LLC grew its stake in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the period. Reilly Financial Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Private Vista LLC grew its stake in shares of Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares during the period. Hanson McClain Inc. grew its stake in shares of Walgreens Boots Alliance by 4.6% during the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares during the period. Finally, Founders Capital Management acquired a new stake in shares of Walgreens Boots Alliance during the first quarter worth $161,000. Institutional investors own 63.35% of the company’s stock.
In related news, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.
Shares of Walgreens Boots Alliance, Inc. (WBA) opened at $71.16 on Wednesday. Walgreens Boots Alliance, Inc. has a twelve month low of $63.82 and a twelve month high of $88.00. The stock has a market capitalization of $71,455.88, a PE ratio of 13.88, a P/E/G ratio of 1.26 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same quarter in the prior year, the company posted $1.07 earnings per share. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.25%. Walgreens Boots Alliance’s payout ratio is presently 42.33%.
Walgreens Boots Alliance announced that its board has initiated a stock repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: This article was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.dispatchtribunal.com/2017/11/22/stifel-financial-corp-sells-120673-shares-of-walgreens-boots-alliance-inc-wba.html.
WBA has been the subject of a number of analyst reports. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Leerink Swann cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 1st. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, October 26th. Finally, SunTrust Banks, Inc. set a $72.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday, October 15th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $87.63.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.